Signet Healthcare Partners

History

Signet Healthcare partners was founded by James Gale and Sanders Morris Harris Group in 1998 with the establishment of the Corporate Opportunities Funds. Since 1998, we have organized three funds and completed investments in approximately 27 companies. SMH Capital has remained a long-term partner with our Funds. The team is comprised of five professionals with principal offices in New York City. This team brings over 100 years experience of collective healthcare experience in the specialty pharmaceutical, medical device, private equity and investment banking businesses.

For the past nine years, Signet Healthcare has maintained its dedicated focus to diversified healthcare investing – primarily serving as lead investor to expansion stage companies engaged in specialty pharmaceuticals, medical devices and the pharma services industries.

Investment Strategy

We seek investment opportunities in which we can play an active and substantial role in helping management perform to their full potential and create shareholder value. We are both minority and majority investors in companies which are close to, or have achieved commercial operations and are seeking expansion stage capital. In general, we target investment opportunities where we can capitalize on operational efficiencies and revenue expansion opportunities through business development activities and product strategies, including life cycle management.

Global Perspective

Innovation, access to technical skills, lower production costs, and sales and marketing opportunities have created opportunities outside the U.S. Since inception of our Funds, we have invested on a global basis with approximately 20% of our funds committed to entities domiciled in Europe and Asia. In general, we invest internationally with strong local investment partners. However, Signet Healthcare monitors these international investments in a manner similar to our domestic positions